Sabine Huenecke
Overview
Explore the profile of Sabine Huenecke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
838
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
von Metzler I, Campe J, Huenecke S, Raab M, Goldschmidt H, Schubert R, et al.
J Mol Med (Berl)
. 2021 Oct;
100(3):463-470.
PMID: 34657968
Multiple myeloma patients are often treated with immunomodulatory drugs, proteasome inhibitors, or monoclonal antibodies until disease progression. Continuous therapy in combination with the underlying disease frequently results in severe humoral...
12.
Zielen S, Duecker R, Woelke S, Donath H, Bakhtiar S, Buecker A, et al.
J Clin Immunol
. 2021 Sep;
41(8):1878-1892.
PMID: 34477998
Patients with ataxia-telangiectasia (A-T) suffer from progressive cerebellar ataxia, immunodeficiency, respiratory failure, and cancer susceptibility. From a clinical point of view, A-T patients with IgA deficiency show more symptoms and...
13.
Bakhtiar S, Salzmann-Manrique E, Donath H, Woelke S, Duecker R, Fritzemeyer S, et al.
Br J Haematol
. 2021 Aug;
194(5):879-887.
PMID: 34337741
Ataxia-telangiectasia (A-T) is a hereditary immune system disorder with neurodegeneration. Its first neurologic symptoms include ataxic gait in early childhood, with slowly progressive cerebellar ataxia, oculomotor apraxia, oculocutaneous telangiectasia, and...
14.
Bremm M, Krastel T, Cappel C, Zimmermann O, Pfeffermann L, Katzki V, et al.
J Immunol Methods
. 2021 Jan;
492:112960.
PMID: 33417916
Background: Recently, new advances were made regarding the depletion of CD45RA naïve T cells from haploidentical grafts as they are suspected to be the most alloreactive. Methods: Within this project...
15.
Heinze A, Grebe B, Bremm M, Huenecke S, Munir T, Graafen L, et al.
Front Immunol
. 2019 Dec;
10:2816.
PMID: 31849984
Neuroblastoma (NB) is the most common solid extracranial tumor in childhood. Despite therapeutic progress, prognosis in high-risk NB is poor and innovative therapies are urgently needed. Therefore, we addressed the...
16.
Duecker R, Baer P, Buecker A, Huenecke S, Pfeffermann L, Modlich U, et al.
Front Immunol
. 2019 Dec;
10:2785.
PMID: 31849966
Ataxia-telangiectasia (A-T) is a multisystem disorder with progressive cerebellar ataxia, immunodeficiency, chromosomal instability, and increased cancer susceptibility. Cellular immunodeficiency is based on naïve CD4 and CD8 T-cell lymphopenia. Hematopoietic stem...
17.
Merker M, Meister M, Heinze A, Jarisch A, Sorensen J, Huenecke S, et al.
Oncotarget
. 2019 Nov;
10(58):6138-6151.
PMID: 31692914
Prognosis of refractory childhood cancers despite multimodal treatment strategies remains poor. Here, we report a single center experience encountered in 18 patients with refractory solid malignancies treated with adoptive cellular...
18.
Bremm M, Pfeffermann L, Cappel C, Katzki V, Erben S, Betz S, et al.
Front Immunol
. 2019 Jun;
10:1218.
PMID: 31214182
Cytokine-induced killer (CIK) cells are an immunotherapeutic approach to combat relapse following allogeneic hematopoietic stem cell transplantation (HSCT) in acute leukemia or myelodysplastic syndrome (MDS) patients. Prompt and sequential administration...
19.
Merker M, Salzmann-Manrique E, Katzki V, Huenecke S, Bremm M, Bakhtiar S, et al.
Biol Blood Marrow Transplant
. 2019 Mar;
25(7):1281-1292.
PMID: 30878607
Well-established donor lymphocyte infusion (DLI) and novel cytokine-induced killer (CIK) cell therapy for the treatment of relapsing hematologic malignancies after allogeneic hematopoietic stem cell transplantation (HSCT) were compared with respect...
20.
Bakhtiar S, Woelke S, Huenecke S, Kieslich M, Taylor A, Schubert R, et al.
Front Immunol
. 2018 Nov;
9:2495.
PMID: 30420857
Ataxia telangiectasia (A-T) is a primary immunodeficiency with mutations in the gene encoding the A-T mutated (ATM) protein that interacts with immune, hematopoietic, and endocrine targets resulting in broad multi-systemic...